10 Best Brain-Computer Interface Stocks to Buy
In this article, we will discuss: 10 Best Brain-Computer Interface Stocks to Buy.
Ceribell Inc. (CBLL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 900,000 | $17,505,000 | +19% | 0.02% |
| 2. | Millennium Management Israel Englander | 727,225 | $14,144,526 | +32% | 0.01% |
| 3. | Royce & Associates Chuck Royce | 605,010 | $11,767,444 | +18% | 0.09% |
| 4. | Redmile Group Jeremy Green | 386,786 | $7,522,988 | 0.51% | |
| 5. | Citadel Investment Group Ken Griffin | 194,724 | $3,787,382 | -33% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 380,268 | $6,464,556.00 | 3,967,422 | 2024-10-15 | Filing | |
| $17.00 | 237,234 | $4,032,978.00 | 2,475,110 | 2024-10-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.38 | 4,887 | $119,145.06 | 203,118 | 2026-10-01 | Filing | |
| $25.03 | 20,846 | $521,775.38 | 746,345 | 2026-09-15 | Filing | |
| $25.00 | 846 | $21,150.00 | 146,600 | 2026-09-15 | Filing | |
| $24.25 | 7,500 | $181,875.00 | 34,144 | 2026-09-08 | Filing | |
| $24.26 | 1,755 | $42,576.30 | 34,144 | 2026-09-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,004 | $170,828 | 0.01% | |
| 2. | 774 | $18,878 | 0% | |
| 3. | 154 | $3,756 | 0% |
News See All
CeriBell, Inc. (NASDAQ:CBLL) Q1 2026 Earnings Call Transcript
CeriBell, Inc. (NASDAQ:CBLL) Q1 2026 Earnings Call Transcript May 11, 2026CeriBell, Inc. misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.39.
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord
CeriBell, Inc. (NASDAQ:CBLL) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. CeriBell, Inc.
12 Most Promising Small-Cap Stocks According to Wall Street Analysts
In this article, we will be taking a look at the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.
CeriBell, Inc. (NASDAQ:CBLL) Q4 2025 Earnings Call Transcript
CeriBell, Inc. (NASDAQ:CBLL) Q4 2025 Earnings Call Transcript February 24, 2026CeriBell, Inc. beats earnings expectations. Reported EPS is $-0.36345, expectations were $-0.43.
CeriBell, Inc. (NASDAQ:CBLL) Q3 2025 Earnings Call Transcript
CeriBell, Inc. (NASDAQ:CBLL) Q3 2025 Earnings Call Transcript November 4, 2025CeriBell, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.43.
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT
CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc.
12 Best Medical Device Stocks to Buy According to Analysts
In this article, we will look at the 12 Best Medical Device Stocks to Buy According to Analysts.
CeriBell, Inc. (NASDAQ:CBLL) Q2 2025 Earnings Call Transcript
CeriBell, Inc. (NASDAQ:CBLL) Q2 2025 Earnings Call Transcript August 5, 2025CeriBell, Inc. beats earnings expectations. Reported EPS is $-0.38, expectations were $-0.4.
Hedge Fund Resource Center